Drug pricing is a conundrum for the country, and apparently for Donald Trump too.
Last week, some pharma CEOs came out of a meeting with the new president believing he’d dropped his previously stated support for direct Medicare negotiation of drug prices. But at a press conference on Tuesday, Press Secretary Sean Spicer said Trump had not, in fact, dropped that support.
